MedTrace Logo

Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease

NCT00667004 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2020-09-03

Study results available
· View outcomes & findings →

Summary

Efficacy study of ecabet ophthalmic solution in dry eye disease

Conditions

Interventions

DRUG

ecabet ophthalmic solution

sterile ophthalmic solution

DRUG

placebo

sterile ophthalmic solution

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Tim McNamara, PharmD · ISTA Pharmaceuticals, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-22
Primary Completion
2008-09-12
Completion
2008-09-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00667004 on ClinicalTrials.gov